Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abatement, adequacy, anesthesiologist, array, aspect, Atlanta, attained, Biden, Biofluidica, biotech, blinded, Brazil, carrier, carryback, clerical, combating, Conformit, counsel, COVID, CSI, CT, ctRNA, cytology, debilitating, EKRA, Emory, equivocal, etcetera, EUA, expedite, expedited, extremely, faster, FFPE, filer, foot, headquartered, heath, home, house, inconvenient, Inivata, Invitae, irreversibly, jury, Kettering, lumbar, Lurie, magnitude, matter, MCCP, Med, Mesa, metastasized, military, mission, Monica, MultiPlan, Northwestern, novo, nurse, nursing, online, Penn, pharma, piece, pool, preapproved, presidential, primer, pronouncement, prorated, puncture, QNS, qPCR, qualification, quantity, queue, radiologic, ratio, RavGen, reconsider, repricing, residual, resume, Rim, risky, RNA, Road, Santa, Scientist, shortage, Sloan, Southern, speculative, Stanford, summarized, supposed, sweeping, tap, transposed, trend, TRICARE, TriWest, trouble, unbilled, unnecessary, unqualified, urgent, usability, vaccinated, vaccine, verified, vet, week, West, withdrawn, workforce
Removed:
Adnagen, Agena, Agendia, Alere, amortizing, Apocell, Atossa, BCT, bioMerieux, cerebral, challenged, circumvented, Clearbridge, Codification, consecutive, converted, Cynvenio, eliminated, entry, essential, expiring, float, Fluxion, GlaxoSmithKline, Grail, hedge, hedged, hedging, infringed, interpret, Israel, Kennedy, line, loan, locally, lymphoma, mainstream, maturity, Michael, microarray, misappropriated, Nall, nonfinancial, optional, Oregon, Oxford, passage, personalization, Pfizer, reclassification, recurring, relocating, resection, retained, ScreenCell, Secretary, simplifying, stranded, Tafinlar, TCTM, Terry, Timothy, Turkey, Unaudited, Uruguay, vast, warehouse, Xalkori, Zelboraf
Filing tables
Filing exhibits
Related press release
Associated BIOCQ transcripts
BIOCQ similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As independent registered public accountants, we hereby consent to the incorporation by reference in Registration Statement Nos. 333-194930, 333-202656, 333-206347, 333-212960, 333-218018, 333-227267, 333-227900, 333-233285, and 333-251676 on Forms S-8, Registration Statement Nos. 333-224946, and 333-237837 on Forms S-3, and Registration Statement Nos. 333-234459, 333-230797, 333-228566, and 333-227908 on Forms S-1 of our report dated March 31, 2021, relating to the financial statements of Biocept, Inc. (“Company”), included in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 31, 2021